Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer - Concepedia

Concepedia

Publication | Closed Access

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer

43

Citations

35

References

1984

Year

Jan G.M. Klijn, Frank H. de Jong, Marinus A. Blankenstein, Roel Docter, J. Alexieva-Figusch, J.Blonk van der Wijst, Steven W. J. Lamberts

Breast Cancer Research and Treatment

Breast OncologyOncologyMedicineBreast CancerPharmacotherapyEndocrinologyPharmacologyRadiation OncologyEndocrine-related CancerEndocrine Effects

References

	Year	Citations

Page 1